menu
    • menu

    Company profile for Noveome Biotherapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Noveome is a clinical-stage biopharmaceutical company advancing ST266— a first-of-its-kind, multi-targeted secretome containing hundreds of biologically active proteins and other factors crucial to neuroprotection, the modulation of inflammation, cell recovery and healing. ST266 contains physiologic levels of hundreds of active biomolecules, including growth factors and cytokines. These molecules modulate a host of biolog...
    Noveome is a clinical-stage biopharmaceutical company advancing ST266— a first-of-its-kind, multi-targeted secretome containing hundreds of biologically active proteins and other factors crucial to neuroprotection, the modulation of inflammation, cell recovery and healing. ST266 contains physiologic levels of hundreds of active biomolecules, including growth factors and cytokines. These molecules modulate a host of biological pathways,

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Noveome BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Technology Drive, Suite 200 Pittsburgh, PA 15219
    Telephone
    Telephone
    +1.412.402.9914
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://noveome.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Noveome Biotherapeutics Announces New Appointments to Board of Directors
    Noveome Biotherapeutics Announces New Appointments to Board of Directors

    16 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221116005292/en/Noveome-Biotherapeutics-Inc.-Announces-New-Appointments-to-Board-of-Directors

    BUSINESSWIRE
    16 Nov 2022
    Share Share
    Noveome Biotherapeutics, Inc. Announces New Appointments to Board of Directors
    Noveome Biotherapeutics, Inc. Announces New Appointments to Board of Directors

    16 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221116005292/en

    BUSINESSWIRE
    16 Nov 2022
    Share Share
    Noveome Receives RPD Designation and ODD for Necrotizing Enterocolitis
    Noveome Receives RPD Designation and ODD for Necrotizing Enterocolitis

    31 May 2022

    // TRIALSITENEWS

    https://www.trialsitenews.com/a/noveome-biotherapeutics-receives-rare-pediatric-disease-designation-and-orphan-drug-designation-for-necrotizing-enterocolitis-in-neonates-013a48e8

    TRIALSITENEWS
    31 May 2022
    Share Share
    Noveome Bio Receives RPD Designation and ODD for Necrotizing Enterocolitis
    Noveome Bio Receives RPD Designation and ODD for Necrotizing Enterocolitis

    24 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220524005099/en

    BUSINESSWIRE
    24 May 2022
    Share Share
    Noveome Biotherapeutics, Inc. Commences Phase 1 Clinical Study of ST266
    Noveome Biotherapeutics, Inc. Commences Phase 1 Clinical Study of ST266

    23 Jun 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/noveome-biotherapeutics-inc-commences-phase-1-clinical-study-of-st266-application-for-infectious-disease-including-covid-19-301318438.html

    PRNEWSWIRE
    23 Jun 2021
    Share Share
    Noveome Announces Preliminary Results of its Phase 1 Clinical Trial of ST266
    Noveome Announces Preliminary Results of its Phase 1 Clinical Trial of ST266

    07 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210607005051/en/Noveome-Biotherapeutics-Inc.-Announces-Preliminary-Results-of-its-Phase-1-Open-Label-Clinical-Trial-Evaluating-Intranasal-Delivery-of-Lead-Candidate-ST266-In-Glaucoma-Suspect-Patients

    BUSINESSWIRE
    07 Jun 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search